Medplus Health Services Limited (MEDPLUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.13 Billion ≈ $33.89 Million USD) by net assets (Rs18.44 Billion ≈ $199.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Medplus Health Services Limited market cap and net worth for the company's overall valuation and market capitalisation.
Medplus Health Services Limited - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Medplus Health Services Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medplus Health Services Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medplus Health Services Limited ranked by their cash flow conversion efficiency. Explore Medplus Health Services Limited cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing Join-Cheer Software Co Ltd
SHE:002279
|
0.064x |
|
Fujian Boss Software Development Co Ltd
SHE:300525
|
0.016x |
|
CHINA RISUN GROUP HD-10
F:45Y
|
N/A |
|
Savencia SA
PA:SAVE
|
0.124x |
|
Wanbangde Pharmaceutical Holding Group Co Ltd
SHE:002082
|
0.000x |
|
Fujian Longxi Bearing Group Co Ltd
SHG:600592
|
0.011x |
|
Wuhan Zhongyuan Huadian Sci Tech
SHE:300018
|
0.071x |
|
Pet Valu Holdings Ltd
TO:PET
|
0.518x |
Annual Cash Flow Conversion Efficiency for Medplus Health Services Limited (2019–2026)
The table below shows the annual cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2026. View today's stock price for Medplus Health Services Limited for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs19.75 Billion ≈ $213.55 Million |
Rs5.27 Billion ≈ $56.99 Million |
0.267x | -16.25% |
| 2025-03-31 | Rs17.40 Billion ≈ $188.16 Million |
Rs5.54 Billion ≈ $59.96 Million |
0.319x | +249.68% |
| 2024-03-31 | Rs15.77 Billion ≈ $170.59 Million |
Rs1.44 Billion ≈ $15.54 Million |
0.091x | +50.23% |
| 2023-03-31 | Rs14.91 Billion ≈ $161.19 Million |
Rs904.10 Million ≈ $9.78 Million |
0.061x | -49.40% |
| 2022-03-31 | Rs14.17 Billion ≈ $153.27 Million |
Rs1.70 Billion ≈ $18.37 Million |
0.120x | +2931.44% |
| 2021-03-31 | Rs7.31 Billion ≈ $79.07 Million |
Rs28.91 Million ≈ $312.65K |
0.004x | +131.75% |
| 2020-03-31 | Rs5.29 Billion ≈ $57.22 Million |
Rs-65.89 Million ≈ $-712.58K |
-0.012x | -102.47% |
| 2019-03-31 | Rs2.91 Billion ≈ $31.51 Million |
Rs1.47 Billion ≈ $15.86 Million |
0.503x | -- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more